Amneal Pharmaceuticals Ratios (2017-2025) | AMRX

1Y3Y5Y7Y10YAll
Download Data
Ratios Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 47.61%53.00%51.61%52.54%43.09%42.00%38.87%18.62%26.01%14.39%27.74%36.81%31.04%25.72%32.76%38.85%39.71%37.55%30.99%35.08%35.85%35.60%35.32%31.96%36.73%37.50%30.77%36.11%35.62%38.37%35.98%36.80%39.51%34.92%
EBT Margin 16.65%10.36%21.16%18.90%-63.44%4.74%-2.98%-29.85%-13.90%6.95%-14.37%2.68%-4.68%-4.22%-1.07%3.02%6.51%-0.39%-3.04%-1.99%-41.61%0.40%-1.26%-1.69%4.95%3.70%-13.53%-11.46%2.91%2.20%-2.10%5.39%7.14%-0.67%
EBIT Margin 16.44%30.92%26.94%23.09%-43.76%15.65%4.68%-21.15%-4.67%-29.68%-5.82%11.59%2.31%0.47%3.96%9.31%12.54%5.39%2.08%4.68%-35.51%8.13%5.91%6.18%13.37%12.20%2.30%-1.63%13.60%12.64%10.38%14.43%15.37%8.97%
EBITDA Margin 16.44%30.92%26.94%23.09%-43.76%15.65%4.68%-21.15%-4.67%-29.68%-5.82%11.59%2.31%0.47%3.96%9.31%12.54%5.39%2.08%4.68%-35.51%8.13%5.91%6.18%13.37%12.20%2.30%-1.63%13.60%12.64%10.38%14.43%15.37%8.97%
Operating Margin 16.44%30.92%26.94%23.09%-43.76%15.65%4.68%-21.15%-4.67%-29.68%-5.82%11.59%2.31%0.47%3.96%9.31%12.54%5.39%2.08%4.68%-35.51%8.13%5.91%6.18%13.37%12.20%2.30%-1.63%13.60%12.64%10.38%14.43%15.37%8.97%
Net Margin 16.26%10.65%21.16%18.76%-4.62%1.46%-1.76%-10.73%-4.18%-70.05%-8.09%23.08%-2.58%-1.73%-0.60%1.36%2.72%-0.80%-1.19%-0.43%-21.60%-0.49%-0.71%-1.25%1.99%1.56%-15.99%-12.39%2.39%1.67%-2.84%3.54%4.92%2.31%
FCF Margin 22.76%-8.39%2.74%-27.96%7.48%48.16%-28.33%2.34%33.54%-13.94%8.36%36.73%6.51%14.98%27.65%-11.17%13.57%8.52%22.01%-23.34%13.65%-5.70%23.32%-3.90%11.25%20.42%-2.06%4.14%17.77%14.09%-0.83%8.42%13.53%
Efficiency
Inventory Average 501.62M473.99M452.76M431.46M408.23M391.45M409.51M440.96M459.86M483.20M493.83M510.20M521.82M504.82M500.81M522.63M538.44M537.30M529.89M539.80M563.52M578.93M576.02M573.14M585.99M604.41M606.94M605.20M611.74M
Assets Average 4,563.32M4,467.39M4,368.66M4,323.36M3,983.04M3,684.92M4,028.34M4,223.78M4,047.15M4,021.78M3,983.05M3,991.56M3,998.73M3,957.04M3,914.32M3,965.19M3,957.72M3,836.69M3,712.97M3,663.75M3,693.98M3,579.82M3,464.48M3,483.16M3,485.45M3,481.21M3,433.35M3,394.02M3,511.33M
Equity Average 927.40M905.84M848.07M774.57M572.54M371.26M375.12M387.24M359.61M346.56M355.82M378.49M386.72M375.07M387.19M290.20M183.64M189.13M159.32M142.72M152.50M87.12M-21.81M-60.56M-75.53M-101.54M-120.76M-122.27M-111.24M
Invested Capital 1,430.21M3,602.22M1,037.01M3,548.41M863.05M812.38M417.19M2,977.31M703.46M3,165.35M3,135.11M3,124.42M403.71M427.27M421.17M3,077.64M445.71M2,825.36M2,831.45M2,805.92M2,726.36M2,730.35M2,726.58M2,440.14M2,347.74M2,345.24M2,300.73M2,276.49M2,053.77M2,065.05M2,463.75M
Asset Utilization Ratio 0.320.370.420.420.430.440.420.410.460.500.500.520.520.530.540.540.540.580.610.630.650.670.720.750.770.800.820.840.84
Leverage & Solvency
Debt to Equity -101.492.833.062.943.313.526.667.597.617.538.008.067.527.057.107.436.6415.6513.7314.4119.7717.7016.97128.18-40.18-41.79-25.59-21.79-18.51-21.65-23.41
Debt Ratio 1.080.580.610.610.600.620.710.720.700.690.690.690.700.680.680.690.700.670.690.700.730.720.710.740.740.680.690.680.730.710.71
Equity Ratio -0.010.210.200.210.180.180.110.090.090.090.090.090.090.100.100.090.100.040.050.050.040.040.040.01-0.02-0.02-0.03-0.03-0.04-0.03-0.03
Dividends & Payouts
FCF Payout Ratio 1.03-0.813.98-1.320.00
Valuation
Enterprise Value -48.22M-19.35M-64.01M5,756.97M5,281.32M6,872.02M4,217.83M4,496.07M2,377.44M832.35M1,290.47M648.63M1,171.53M893.32M1,040.26M1,578.78M1,276.09M1,322.05M1,213.25M1,063.37M889.20M548.16M603.12M304.88M869.73M1,242.85M1,810.47M1,860.96M1,969.59M2,561.28M2,408.39M2,610.94M2,529.82M3,010.46M
Market Capitalization 5,805.20M4,897.85M6,623.00M4,039.61M4,232.44M2,142.64M867.36M1,441.66M1,041.31M1,425.29M1,162.67M1,369.84M2,017.80M1,540.29M1,609.45M1,444.13M1,257.43M963.30M613.12M604.15M422.03M946.91M1,292.64M1,860.72M1,860.46M1,959.94M2,575.39M2,453.97M2,597.52M2,535.56M3,143.93M
Return Ratios
Return on Sales 0.17%-0.09%-0.08%-0.12%-0.21%-0.10%-0.32%-0.37%-0.21%-0.19%0.01%0.03%-0.02%0.01%0.02%0.01%0.00%-0.13%-0.13%-0.12%-0.11%0.00%0.02%-0.02%-0.05%-0.05%-0.05%-0.03%0.01%0.02%0.02%
Return on Capital Employed 0.01%-0.01%-0.05%0.00%-0.06%-0.08%-0.03%-0.02%0.01%0.03%0.02%0.04%0.05%0.05%0.04%-0.05%-0.04%-0.03%-0.03%0.07%0.08%0.07%0.06%0.07%0.08%0.11%0.15%0.16%0.14%
Return on Invested Capital 0.01%-0.01%-0.08%-0.02%0.26%0.30%0.06%0.05%0.09%0.10%0.13%
Return on Assets -0.03%-0.05%-0.09%-0.04%-0.14%-0.16%-0.09%-0.08%0.00%0.02%-0.01%0.00%0.01%0.01%0.00%-0.07%-0.07%-0.07%-0.07%0.00%0.01%-0.01%-0.03%-0.04%-0.04%-0.02%0.01%0.02%0.02%
Return on Equity -0.13%-0.22%-0.45%-0.23%-0.98%-1.62%-0.95%-0.85%0.03%0.20%-0.11%0.05%0.09%0.05%0.00%-0.94%-1.47%-1.35%-1.62%0.08%0.25%-0.56%5.52%2.20%1.94%0.73%-0.27%-0.42%-0.52%